MCP-1-Induced Migration of NT2 Neuroprogenitor Cells Involving APP Signaling

Abstract

Neuroprogenitor cells are an important resource because of their great potential to replace damaged cells in the brain caused by trauma and disease. Studies have shown that when neuroprogenitor cells are transplanted into the brain they migrate towards damaged areas, suggesting that these areas express factors that recruit migrating cells. Generally, after neuronal injury, there is a neuroinflammatory response that results in increased chemokine production. In this present study, we demonstrate that monocyte chemoattractant protein-1 (MCP-1) significantly induces the migration of NT2 neuroprogenitor cells. Activation of intracellular cyclic adenosine monophosphate or protein kinase C with forskolin and phorbol 12-myristate 13-acetate, respectively, was able to completely abolish the MCP-1-induced migration. Contrarily, neither extracellular signal-regulated kinase nor p38 mitogen-activated protein kinase was required for NT2 cells to respond to MCP-1. Previously, we showed that amyloid precursor protein (APP) activity increases MCP-1 expression in NT2 cells. We now demonstrate that NT2 cells expressing APP can induce migration of other neuroprogenitor cells. Utilizing a MCP-1 neutralizing antibody, we discovered that APP-induced migration was not caused solely by increased MCP-1 production. Interestingly, APP-increased expression of several C-C chemokines: MCP-1, regulated upon activation, normal T-cell expressed, and secreted (RANTES), and macrophage inflammatory protein alpha (MIP-1 alpha). This demonstrates the unique role APP has in regulating chemokine production, which directly affects cell migration. Taken together, these data provides greater detail of the chemotactic factors and intracellular signaling that direct neuroprogenitor cell migration, allowing for better understanding of cell migration during transplantation.

From Blood to Lesioned Brain: An In Vitro Study on Migration Mechanisms of Human Nasal Olfactory Stem Cells

“…These results are in agreement with previous studies showing that CCL2 affects neuroblasts, at 500 ng/mL [29] or on BM-MSCs from 75 ng/mL, in modified Boyden chambers [61]. However, numerous in vitro studies reported a CCL2 effect at lower concentrations (150 pg/mL to 10 ng/mL) on neuroblasts and mesenchymal stem cells [28, 56, 57, 59, 62, 63]. In most cases, the studied cells expressed the CCR2 receptor.…”

Autism as early neurodevelopmental disorder: evidence for an sAPPα-mediated anabolic pathway

“…sAPPα facilitates substrate adhesion in cell culture (Wehner et al, 2004). Induction of neuroprogenitor migration by sAPPα may be due to sAPPα upregulation of C–C chemokine levels (Vrotsos and Sugaya, 2009). sAPPα induces synaptogenesis in response to increases in ADAM10 (a disintegrin and metalloproteinase domain-containing protein 10; α-secretase) levels (Bell et al, 2008).…”

Stem cells for the treatment of neurodegenerative diseases

“…We found that APP increased chemokine levels to alter cell migration [41]. We also showed that increased APP caused glial differentiation of human NSCs in vitro and in vivo .…”